Cirrhosis Clinical Trial
Official title:
Effect of Music on Attention and Prospective Memory in Hepatic Encephalopathy
Hepatic encephalopathy (HE) is a potentially reversible, metabolically caused complication
of acute or chronic liver diseases such as cirrhosis. Due to the diseased liver's inability
to remove toxins such as ammonia, which is produced in the gastrointestinal tract, the
ammonia accumulates in the brain and causes forgetfulness, confusion, disorientation,
concentration and memory problems, changes in mood, decreased alertness and responsiveness,
changes in sleep habits, muscle tremors and stiffness, speech impairments, uncontrollable
movements, agitation.
This study will examine music as a possible external factor that could contribute to
impairment in attention and progressive memory in cirrhotic patients while driving.
Sustaining attention is important for learning and remembering new information, for e.g.
keeping the car within lane and paying attention to cyclists and pedestrians. Prospective
memory is the ability to remember to perform previously intended tasks at the appropriate
time or occasion, for instance remembering the correct exit while driving on the highway.
Impairment in any of these areas may result in serious consequences for patient with
cirrhosis. There is evidence that some subsets of cirrhotic patients have a diminished
ability to drive and significantly more motor vehicle crashes and traffic violations. In
these patients, listening to music while driving may further jeopardize their driving
ability, which in turn may lead to reduced quality of life and increased medical costs (from
motor vehicle accidents).
This is a cross-sectional study designed to determine if there is any effect of listening to
music on attention and prospective memory in patients with cirrhosis. For these purposes,
subjects will be asked to come for one study visit, which will last approximately 2 hours.
During this visit, subjects will undergo a series of screening procedures (consent,
assignment of subject identification number, demographics, medical history, physical
examination, vitals, height, weight, and eligibility assessment). If they are found
eligible, subjects will undergo several neuropsychological assessments to measure any effect
of music on attention and prospective memory. These assessments include including Number
Connection Test (NCT), Digit Symbol Test (DST), Cambridge Prospective Memory Test
(CAMPROMPT) and Inhibitory Control Test (ICT).
Cirrhosis occurs when scar tissue replaces healthy liver tissue, partially blocking blood
flow and preventing the liver's ability to control infections, removes bacteria and toxins
from the blood, and to produce proteins to regulate blood clotting and bile to absorb fats
and fat-soluble vitamins. With an estimated prevalence between five and ten percent,
cirrhosis is the twelfth leading cause of death by disease, leading to 27,000 deaths per
year. Heavy alcohol consumption and hepatotropic viruses (hepatitis B and C) are the major
contributors to this disease's prevalence (NDDIC, 2003).
Hepatic encephalopathy (HE) is a potentially reversible, metabolically caused complication
of acute or chronic liver diseases such as cirrhosis, which is characterized by
neuropsychiatric abnormalities. Nearly 70% of cirrhotic patients experience mild levels of
HE and approximately 30% of end-stage patients experience significant HE symptoms, many
approaching coma (Mullen et al., 1999). Although the pathophysiology of HE is not yet
clearly understood, the accumulation of ammonia in the brain due to the liver's inability to
remove toxins (including ammonia) is thought to play a key role in the pathogenesis of HE.
Other factors, which are not mutually exclusive, include increased GABA-ergic tone,
selective alterations of the blood-brain barrier permeability and changes in
neurotransmitter systems. The broad spectrum of symptoms in HE include forgetfulness,
confusion, disorientation, concentration and memory problems, changes in mood, decreased
alertness and responsiveness, changes in sleep habits, muscle tremors and stiffness, speech
impairments, uncontrollable movements, agitation (Ferenci et al., 2002).
The diagnosis of HE is essentially based on clinical history and laboratory findings such as
elevated ammonia levels. Additionally, specialized psychometric tests such as the number
connection test (NCT), Digit Symbol Test (DST) and Psychometric Hepatic Encephalopathy Score
(PHES) have been used in quantifying the minor deficits that may be present in patients with
early HE.
Minimal hepatic encephalopathy (MHE) is a category of early HE without any overt
neuropsychiatric symptoms but with subtle cognitive deficits (Ferenci et al., 1998). It is a
common complication of cirrhosis and has been reported in 20% to 74% of patients (Dhiman et
al., 2010), depending on the test used for diagnosis. It results in deficits in specific
cognitive domains such as attention, vigilance, response inhibition, executive function and
prospective memory. These deficits are often not apparent from a routine neurological exam
or MMSE but can be detected on psychometric testing. The prompt identification and treatment
of MHE are essential because MHE predicts progression to overt HE and impairs the capacity
to drive which can have a significant impact on patients' quality of life (Romero-Gomez et
al., 2001; Wein et al, 2004) .
Treatment of HE with or without liver transplantation has been shown to reverse the
cognitive deficits and improve quality of life (Prasad et al., 2007; Sidhu et al., 2011).
Although the PHES and NCT are the gold standard for diagnosing MHE, their utility is limited
due to expensive copyright, a need for trained psychologists and the lack of reimbursements
from insurance companies. A simpler test would therefore be beneficial to internists who
could easily implement it in the clinic setting.
The inhibitory control task (ICT) is a computerized psychometric test that has been
introduced recently as a diagnostic tool for MHE. It measures the ability to sustain
attention and to inhibit responses to relevant stimuli, 2 basic cognitive domains that are
impaired in MHE. During the ICT, the patient is presented with a continuous stream of
letters at 500-ms intervals and interspersed within these letters are the letters X and Y.
Subjects are instructed to only respond when the letters "X" and "Y" are alternated (called
targets), independent of the letters between them. In contrast, patients are instructed to
refrain from responding, i.e. inhibit their response, when "X" and "Y" are not alternating
(called lures). Higher rates of target response, lower rates of lure response and shorter
reaction times indicate better attention and response inhibition. One study by Bajaj et al.
(2008) showed the ICT to be a reliable test with 87% sensitivity for the diagnosis of MHE,
with MHE patients having higher ICT lures and lower targets compared to patients without
MHE.
Patients with MHE have deficits in attention and prospective memory which are cognitive
domains that are important to activities such as driving. Sustaining attention is important
for learning and remembering new information, for e.g. keeping the car within the lane while
driving and paying attention to pedestrians and cyclists. Prospective memory involves both
working memory (to formulate, initiate, and modify plans of action) and retrospective memory
(to recall what needs to be done at a particular time or in response to an external cue),
for instance, remembering the correct exit while driving on the highway. The act of driving
requires the ability to sustain attention and utilize prospective memory under stressful
conditions. Impairment in any of these areas may result in serious consequences for patient
with chronic liver disease, such as cirrhosis. Indeed, some studies of cirrhotic patients
have shown that those with MHE have a diminished ability to drive and significantly more
motor vehicle crashes and traffic violations than those without MHE (Bajaj et al., 2007,
2009). The reasons behind this are thought to be not only the obvious cognitive deficits,
but also a greater tendency to fatigue at the wheel and poor insight into the cognitive
deficiencies (Kircheis et al., 2009). In fact, driving simulator tests and questionnaire
surveys have shown that patients with MHE who have been diagnosed using the ICT have
impaired navigational skills and significantly higher crash rates (Bajaj et al., 2008,
2009).
In addition to the potential value of the ICT in detecting MHE, the test may be useful in
uncovering temporary insults to attention and working memory that may arise in the presence
of external stimuli such as music. Listening to music while driving is a pervasive practice
and the relationship between background music and driving performance has been studied in
the past (Unal et al., 2012; van der Zwaag et al., 2012). However these studies did not
specifically address patients with cirrhosis, who are a population at higher risk of traffic
accidents. The hypothesis of our study are (1) cirrhotic patients with MHE are expected to
have lower ICT scores than patients without MHE and (2) these deficits are expected to
worsen in the presence of music, suggesting music as a possible factor that could contribute
to impaired attention and working memory, and hence impaired driving ability in cirrhotic
patients. To this end, various types of music, including classical and heavy metal, will be
used as a means of distracting cirrhotic patients while they are administered the ICT, to
determine if there is any effect of listening to music on ICT scores. In addition to the
ICT, the Digit Symbol Test, Number Connection Test, Cambridge Prospective Memory Test
(CAMPROMPT), Stroop test, Fisk Fatigue Impact Scale and Epworth Sleepiness Scale will also
be administered to quantify the degree of HE. While the use of ICT may not be appropriate
for definitively predicting driving fitness, it may be valuable in uncovering deficits in
attention and memory that arise while listening to music, which may ultimately aid in the
counseling and education of patients regarding safe driving practices.
;
Observational Model: Case-Only, Time Perspective: Cross-Sectional
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01884415 -
Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosis
|
Phase 3 | |
Recruiting |
NCT05014594 -
Sodium-glucose Linked Transporter 2 (SGLT-2) Inhibitors in Recurrent Ascites: a Pilot RCT
|
Phase 2 | |
Not yet recruiting |
NCT03631147 -
The Effect of Rifaximin on Portal Vein Thrombosis
|
N/A | |
Completed |
NCT04939350 -
Evaluation of the Vaccination Coverage of Cirrhotic Patients Followed in the General Hospitals in France in 2021
|
||
Completed |
NCT02528760 -
To Determine the Role of Prokinetics in Feed Intolerance in Critically Ill Cirrhosis
|
N/A | |
Recruiting |
NCT05484206 -
Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434
|
Phase 1 | |
Not yet recruiting |
NCT05538546 -
Baveno VI Criteria in Dynamic Monitoring of High-risk Varices in Compensated Cirrhotic Patients
|
||
Not yet recruiting |
NCT04053231 -
Hepatocarcinoma Recurrence on the Liver Study - Part2
|
||
Recruiting |
NCT02983968 -
Use of the French Healthcare Insurance Database
|
||
Completed |
NCT02705534 -
Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1
|
Phase 3 | |
Completed |
NCT02596880 -
Sofosbuvir, Daclatasvir, Ribavirin for Hepatitis C Virus (HCV) Cirrhotics
|
Phase 3 | |
Completed |
NCT02247414 -
Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection
|
Phase 4 | |
Withdrawn |
NCT01956864 -
Study of High-Dose Oral Vitamin D for the Prevention of Liver Cancer
|
Phase 1 | |
Completed |
NCT02016196 -
Rifaximin vs Placebo for the Prevention of Encephalopathy in Patients Treated by TIPS
|
Phase 3 | |
Completed |
NCT02113631 -
Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir
|
N/A | |
Completed |
NCT01447537 -
Mechanisms Involved in the Benefits of an Exercise Programme in Patients With Cirrhosis
|
N/A | |
Completed |
NCT01362855 -
Advance Care Planning Evaluation in Hospitalized Elderly Patients
|
||
Active, not recruiting |
NCT01205074 -
¹³C-Methacetin Breath Test (MBT) Methodology Study
|
Phase 2/Phase 3 | |
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Completed |
NCT01231828 -
Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies.
|
N/A |